[Multiple myeloma].
Masahiro Abe1, Hirokazu Miki, Shingen Nakamura
1Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School.
Achieving complete remission (CR) is crucial for multiple myeloma patients, guiding treatment decisions for better survival outcomes. Effective combination therapies and novel agents are key to managing this heterogeneous cancer.
Area of Science:
- Hematology
- Oncology
- Clinical Pharmacology
Context:
- Multiple myeloma is a heterogeneous plasma cell malignancy.
- Treatment strategies are evolving with new therapeutic agents.
- Complete remission (CR) serves as a surrogate for overall survival.
Purpose:
- To outline current and future treatment paradigms for multiple myeloma.
- To emphasize the importance of achieving CR for improved patient outcomes.
- To highlight the need for effective therapies for relapsed/refractory disease.
Summary:
- Current multiple myeloma treatment emphasizes a "one-size-fits-all" approach using proteasome inhibitors and immunomodulatory drugs (IMiDs) as backbone therapy.
- Consolidation and maintenance strategies aim to achieve CR for extended survival.
- Myeloma-defining biomarkers aid in identifying high-risk smoldering myeloma requiring intervention.
Impact:
- The integration of novel molecular targeting and immunotherapeutic agents promises significant therapeutic advancements.
- Further evolution of treatment strategies is anticipated to improve outcomes for all multiple myeloma patients.
- Development of salvage treatments is critical for relapsed/refractory multiple myeloma.
More Related Videos
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Related Concept Videos
01:31Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
01:27Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...